Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last A$2.73 AUD
Change Today +0.01 / 0.37%
Volume 10.3M
As of 2:10 AM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

healthscope ltd (HSO) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/3/15 - A$3.15
52 Week Low
07/28/14 - A$2.09
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for HEALTHSCOPE LTD (HSO)

Related News

No related news articles were found.

healthscope ltd (HSO) Related Businessweek News

No Related Businessweek News Found

healthscope ltd (HSO) Details

Healthscope Limited provides private health care services. The company’s Hospitals segment offers medical and surgical services in the fields of intensive care, maternity, cardiac, orthopaedics, urology, oral, gynaecology, endoscopy, vascular, and ear, nose, and throat surgery, as well as provides general, plastic, other specialist and day surgery. This segment also provides treatment for anxiety, depression, schizophrenia, post-traumatic stress, eating disorders, alcohol and drug addiction, and obsessive compulsive disorders; and rehabilitation services for patients with acquired brain injury, musculoskeletal injuries, cardiac and stroke, and pain management. It operates 44 private hospitals with approximately 4,400 beds, including 31 acute hospitals, 7 psychiatric hospitals, and 6 rehabilitation and extended care facilities, as well as operates independent living housing facilities. Its International Pathology segment provides various pathology services primarily under the Labtests, SCL, and Northland brands; and general practitioner, specialist, hospital, and corporate screening services, as well as offers women’s and children’s health services. It operates 13 laboratories in New Zealand; 26 laboratories in Malaysia; and 1 central laboratory in Singapore, as well as manages 1 laboratory in Vietnam. The company’s Australian Pathology segment provides anatomical, biochemistry, haematology, microbiology, and molecular pathology services; and general practice management services, as well as operates one specialist breast diagnostic clinic in Sydney. As of May 19, 2014, it operated 578 collection centers and 69 accredited laboratories; and 46 medical centers and 11 specialist skin cancer clinics. The company was formerly known as Healthscope Hospitals Holdings Pty. Ltd. Healthscope Limited was founded in 1985 and is based in Melbourne, Australia. Healthscope Limited operates as a subsidiary of Healthscope Group.

Founded in 1985

healthscope ltd (HSO) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

healthscope ltd (HSO) Key Developments

Healthscope Quashes Talk On Healthe Care

Healthscope Limited (ASX:HSO) has quashed rumours that it is in talks to buy all or part of rival hospital group Healthe Care Australia Pty Ltd., prompting owner Archer Capital Pty Ltd. to deny the business is up for sale. "Apart from what I have been reading in the newspapers I really don't know much about any potential sale of Healthe Care at this stage," Healthscope Chief Executive Robert Cooke said. "There's not much in the Healthe portfolio that would interest us," he added. "Our business is performing very well, however, there is no sale process being run, no sale advisers have been appointed, and it is not a priority at this time," Archer Capital Managing Director, Steve Atkins said. "Healthe Care remains very focused on growing and improving its hospitals for the doctors, patients and communities we serve."

Healthscope Limited Presents at 12th Annual Australia & New Zealand Investment Conference, Mar-09-2015

Healthscope Limited Presents at 12th Annual Australia & New Zealand Investment Conference, Mar-09-2015 . Venue: The Corinthia Hotel, 10 Whitehall Place, London SW1A 2BD, United Kingdom. Speakers: Anita Healy, GM Business Development & Investor Relations, Michael Sammells, Chief Financial Officer.

Healthscope Limited Announces Interim Dividend, Payable on or About March 24, 2015

Healthscope Limited announced interim dividend of $0.0330 per security. Ex-distribution/entitlement date is March 5, 2015. Record date is March 10, 2015. Payable on or about March 24, 2015.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HSO:AU A$2.73 AUD +0.01

HSO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Primary Health Care Ltd A$5.23 AUD -0.06
Sonic Healthcare Ltd A$19.76 AUD -0.01
View Industry Companies

Industry Analysis


Industry Average

Valuation HSO Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HEALTHSCOPE LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at